- Home
- CLDX vs MGNI Comparison
CLDX vs MGNI Comparison
Compare CLDX & MGNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- MGNI
- Stock Information
- Founded
- CLDX N/A
- MGNI 2007
- Country
- CLDX United States
- MGNI United States
- Employees
- CLDX N/A
- MGNI N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- MGNI Computer Software: Programming Data Processing
- Sector
- CLDX Health Care
- MGNI Technology
- Exchange
- CLDX Nasdaq
- MGNI Nasdaq
- Market Cap
- CLDX 1.3B
- MGNI 1.4B
- IPO Year
- CLDX 2008
- MGNI N/A
- Fundamental
- Price
- CLDX $20.10
- MGNI $15.88
- Analyst Decision
- CLDX Buy
- MGNI Strong Buy
- Analyst Count
- CLDX 9
- MGNI 14
- Target Price
- CLDX $50.00
- MGNI $18.93
- AVG Volume (30 Days)
- CLDX 664.5K
- MGNI 2.9M
- Earning Date
- CLDX 05-08-2025
- MGNI 05-07-2025
- Dividend Yield
- CLDX N/A
- MGNI N/A
- EPS Growth
- CLDX N/A
- MGNI N/A
- EPS
- CLDX N/A
- MGNI 0.21
- Revenue
- CLDX $7,559,000.00
- MGNI $674,622,000.00
- Revenue This Year
- CLDX N/A
- MGNI $2.65
- Revenue Next Year
- CLDX N/A
- MGNI $11.26
- P/E Ratio
- CLDX N/A
- MGNI $74.09
- Revenue Growth
- CLDX 24.49
- MGNI 5.59
- 52 Week Low
- CLDX $14.40
- MGNI $8.22
- 52 Week High
- CLDX $47.00
- MGNI $21.29
- Technical
- Relative Strength Index (RSI)
- CLDX 53.76
- MGNI 70.82
- Support Level
- CLDX $18.47
- MGNI $11.80
- Resistance Level
- CLDX $20.42
- MGNI $16.86
- Average True Range (ATR)
- CLDX 1.29
- MGNI 0.67
- MACD
- CLDX -0.02
- MGNI 0.51
- Stochastic Oscillator
- CLDX 60.32
- MGNI 81.82
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About MGNI Magnite Inc.
Magnite Inc is one of the supply-side platform providers, or SSP, in online advertising. The firm generate its revenue from the programmatic sale of CTV ad inventory, from mobile online sites and apps, and the remaining from websites accessed via computer.